In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...

Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, ...

The policy was the buzz of the International Society for Health Economics and Outcomes Research (ISPOR) annual European ...

J&J said first-quarter revenues came in at $21.9 billion, up 2.4% on the same period of 2024, which was a little above ...

Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation ...

AI and digital health have tremendous potential to improve patient outcomes across healthcare, but in rare disease – where small patient groups, delayed diagnosis, and barriers to access create major ...

For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than ...

In the video below, Androsavich explains how Ginkgo Datapoints generates data and provides it as a service to pharma ...

For example, if they are trained on data that reflects existing disparities in treatment or demographics, the AI could ...